Slowing the climb is the main lever
The latest dual-action GLP-1 analogue, tirzepatide , which also affects GIP receptors, was approved in the US in 2022 as the drug Mounjaro for the treatment of type 2 diabetes, and in 2023 as Zepbound for the treatment of obesity and excess weight, as well as obstructive sleep apnea syndrome in obese individuals
Importantly, the mere presence of PanIN lesions is not necessarily problematic, as low-grade PanINs are present in 50-80% of adults and do not universally transform into malignancy 21
A defining feature of these systems is their integration of mechanical activity, structural integrity, and metabolic demand into unified endocrine networks
After 30 years, cardiovascular mortality rates for liraglutide 1.2 mg, 1.8 mg, and rosiglitazone reached 69.7%, 68.4%, and 72.5%
Inspect your pen to make sure it isnt expired or damaged and check that the medication is clear and colourless in the window of the pen